Michelle Mello

Michelle Mello Stanford

Michelle Mello, JD, PhD

  • Professor, Health Policy
  • Professor, Law
(650) 725-3894 (voice)

Biography

Michelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine.  She conducts empirical research into issues at the intersection of law, ethics, and health policy.  She is the author of more than 230 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, health information privacy, and other topics.
 
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40.  From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
 
Dr. Mello teaches courses in torts, public health law, and health policy.  She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University. 

In The News

Chip Kahn and Michelle Mello for KFF podcast
Q&As

Podcast: Guardrails for AI in Health Care—How High?

AI is racing into everyday medicine, yet the rules of the road are still being written. SHP's Michelle Mello joins this KFF podcast to discuss.
Podcast: Guardrails for AI in Health Care—How High?
Nurse and Patient using AI to explain medical tests
Commentary

The Importance of Engaging Patients in Health Care AI Governance

In this editorial, SHP's Michelle Mello and colleagues write that involving patients in AI governance is both feasible and beneficial.
The Importance of Engaging Patients in Health Care AI Governance
A photo illustration of an AI Agent for healthcare
Commentary

Utah Steps into Autonomous AI Medicine with Prescription Renewal Pilot Program

In this JAMA Health Forum commentary, SHP's Michelle Mello discusses the potential pros and cons of a new pilot project in Utah, which is testing an AI agent to renew prescriptions.
Utah Steps into Autonomous AI Medicine with Prescription Renewal Pilot Program